Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral methotrexate plus glucocorticoid for pemphigus
ChiCTR-TRC-12003539Phase 4Completed
- Sponsor
- Institute of Dermatology, Chinese Academy of Medical Sciences
- Start
- Jan 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in pemphigus comparing Glucocorticoid alone with Glucocorticoid plus methotrexate (2 arms). Primary endpoints: PDAI score, Time to complete drying of erosion surfaces and 3 more. Started Jan 2011; status: completed.
02
Drugs
methotrexateprednisone
03
Conditions
pemphigus
Beyond the preview
Go deeper on ChiCTR-TRC-12003539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12003539.